Toxicity of carboplatin in combination with paclitaxel in patients. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Cell Line, Tumor Tumor Cells, Cultured Microtubules

Organisms2

Mice, Nude Taxus

Diseases48

Ovarian Neoplasms Lung Neoplasms Carcinoma, Non-Small-Cell Lung Thrombocytopenia Neutropenia Fallopian Tube Neoplasms Leukopenia Hematologic Diseases Neoplasms Breast Neoplasms Peritoneal Neoplasms Retinal Neoplasms Carcinoma, Small Cell Neoplasm Recurrence, Local Drug Hypersensitivity Retinoblastoma Nausea Carcinoma Neoplasms, Glandular and Epithelial Peripheral Nervous System Diseases Alopecia Germinoma Testicular Neoplasms Adenocarcinoma Vomiting Seminoma Neoplasms, Germ Cell and Embryonal Disease Progression Head and Neck Neoplasms Urologic Neoplasms Neoplasms, Unknown Primary Genital Neoplasms, Female Carcinoma, Squamous Cell Cystadenocarcinoma, Serous Brain Neoplasms Neoplasm Metastasis Bone Marrow Diseases Carcinoma, Large Cell Stomatitis Agranulocytosis Anemia Glioma Adenocarcinoma, Bronchiolo-Alveolar Carcinoma, Transitional Cell Endometrial Neoplasms Drug-Related Side Effects and Adverse Reactions Hearing Loss, High-Frequency Recurrence

Chemicals and Drugs55

Carboplatin Paclitaxel Antineoplastic Agents, Phytogenic Cisplatin Antineoplastic Agents Etoposide Platinum Ifosfamide Deoxycytidine Taxoids Organoplatinum Compounds Doxorubicin Topotecan Vinblastine Cyclophosphamide Thiotepa Amifostine Bridged Compounds Antibodies, Monoclonal, Humanized Epothilones Epirubicin Fluorouracil Platinum Compounds Isocoumarins Contactins Estramustine Mesna Tubulin Guanine Camptothecin Antibodies, Monoclonal P-Glycoprotein Polyethylene Glycols Glutamates Pharmaceutical Vehicles Protein Phosphatase 1 Radiation-Sensitizing Agents Antineoplastic Agents, Alkylating Antimetabolites, Antineoplastic Quinazolines Drug Carriers Albumins Melphalan Antibiotics, Antineoplastic Angiogenesis Inhibitors Folic Acid Transporters Anthracyclines Cyclosporins Triethylenephosphoramide Polyglutamic Acid Niacinamide Receptor, erbB-2 Methotrexate DNA Adducts Mitoxantrone

Analytical, Diagnostic and Therapeutic Techniques and Equipment49

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Treatment Outcome Infusions, Intravenous Combined Modality Therapy Area Under Curve Maximum Tolerated Dose Disease-Free Survival Toxicity Tests Survival Analysis Survival Rate Neoplasm Staging Drug Evaluation Toxicity Tests, Acute Feasibility Studies Salvage Therapy Remission Induction Chemotherapy, Adjuvant Drug Screening Assays, Antitumor Administration, Oral Xenograft Model Antitumor Assays Drug Delivery Systems Kaplan-Meier Estimate Dose Fractionation Pharmaceutical Vehicles Radiotherapy Dosage Prognosis Early Termination of Clinical Trials Follow-Up Studies Drug Carriers Lethal Dose 50 Infusions, Parenteral Chemoradiotherapy Transplantation, Autologous Inhibitory Concentration 50 Hyperthermia, Induced Prospective Studies Hematopoietic Stem Cell Transplantation Radiotherapy, Adjuvant Clinical Trials, Phase I as Topic Injections, Intravenous Retrospective Studies Clinical Trials, Phase II as Topic Metabolic Clearance Rate Pilot Projects Neoplasm Transplantation Radiotherapy, Conformal Toxicity Tests, Chronic Radiotherapy

Phenomena and Processes15

Dose-Response Relationship, Drug Area Under Curve Maximum Tolerated Dose Drug Resistance, Neoplasm Drug Synergism Time Factors Cell Survival Apoptosis Drug Interactions Lethal Dose 50 Drug Resistance, Multiple Inhibitory Concentration 50 Metabolic Clearance Rate Tissue Distribution DNA Adducts

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Technology, Industry, Agriculture2

Polyethylene Glycols Nanoparticles

Humanities1

Quality of Life

Information Science2

Survival Rate Radiotherapy, Conformal

Health Care15

Treatment Outcome Area Under Curve Disease-Free Survival Survival Analysis Survival Rate Population Characteristics Feasibility Studies Kaplan-Meier Estimate Early Termination of Clinical Trials Follow-Up Studies Prospective Studies Clinical Trials, Phase I as Topic Retrospective Studies Clinical Trials, Phase II as Topic Pilot Projects

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Health Care

Carboplatin Paclitaxel Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents, Phytogenic Drug Administration Schedule Ovarian Neoplasms Cisplatin Antineoplastic Agents Lung Neoplasms Treatment Outcome Infusions, Intravenous Carcinoma, Non-Small-Cell Lung Dose-Response Relationship, Drug Etoposide Platinum Ifosfamide Combined Modality Therapy Area Under Curve Thrombocytopenia Maximum Tolerated Dose Neutropenia Disease-Free Survival Deoxycytidine Taxoids Toxicity Tests Organoplatinum Compounds Survival Analysis Fallopian Tube Neoplasms Leukopenia Doxorubicin Drug Resistance, Neoplasm Survival Rate Neoplasm Staging Hematologic Diseases Neoplasms Topotecan Vinblastine Cyclophosphamide Breast Neoplasms Peritoneal Neoplasms Thiotepa Retinal Neoplasms Amifostine Drug Synergism Cell Line, Tumor Carcinoma, Small Cell Neoplasm Recurrence, Local Population Characteristics Bridged Compounds Antibodies, Monoclonal, Humanized Drug Evaluation Drug Hypersensitivity Retinoblastoma Epothilones Nausea Toxicity Tests, Acute Carcinoma Epirubicin Neoplasms, Glandular and Epithelial Fluorouracil Feasibility Studies Salvage Therapy Remission Induction Chemotherapy, Adjuvant Platinum Compounds Peripheral Nervous System Diseases Drug Screening Assays, Antitumor Isocoumarins Alopecia Time Factors Germinoma Testicular Neoplasms Adenocarcinoma Cell Survival Administration, Oral Vomiting Apoptosis Seminoma Contactins Neoplasms, Germ Cell and Embryonal Disease Progression Tumor Cells, Cultured Mice, Nude Head and Neck Neoplasms Estramustine Mesna Tubulin Urologic Neoplasms Guanine Camptothecin Neoplasms, Unknown Primary Antibodies, Monoclonal Taxus P-Glycoprotein Xenograft Model Antitumor Assays Drug Interactions Genital Neoplasms, Female Polyethylene Glycols Glutamates Drug Delivery Systems

No FAQ available that match "toxicity of carboplatin in combination with paclitaxel in patients"